Indoco Remedies Ltd. (INDOCO) Share Price Rises 10.10% Today
- September 2, 2026
- Posted by: Harsh Piplani
- Category: News
Indoco Remedies Ltd. Share Price rose to Rs 267, up 10.10% today, taking market capitalisation to Rs 2,246.67 crore.
Indoco Remedies Ltd. Share Price climbed from the previous close of Rs 242.5 to Rs 267, a gain of Rs 24.5 or 10.1%. The stock opened at Rs 243.45, traded between Rs 241.3 and Rs 267, and the supplied snapshot showed it at the day’s high. Turnover stood at Rs 0.76 crore. The data confirms a strong one-day move, but it does not identify a company-specific catalyst.
That is why today’s move is being watched alongside valuation and profitability. The available figures show a market cap of Rs 2,246.67 crore, P/E of 397.58, P/B of 2.24, ROE of -10.13, ROCE of 0.79, EPS of Rs 0.61, book value of Rs 108.15 and dividend yield of 0.08. In short, price strength today sits beside fundamentals that remain well away from industry medians on several measures.
Indoco Remedies Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 267 |
| Previous Close | Rs 242.5 |
| Today's Move | Rs 24.5 (+10.1%) |
| Open | Rs 243.45 |
| High | Rs 267 |
| Low | Rs 241.3 |
| Turnover | Rs 0.76 crore |
| Market Capitalisation | Rs 2,246.67 crore |
| Market Cap Category | Small Cap |
Indoco Remedies Ltd. (INDOCO) rose to Rs 267 from the previous close of Rs 242.5, a move of Rs 24.5 or 10.1%. The stock opened at Rs 243.45, reached a high of Rs 267, recorded a low of Rs 241.3.
Indoco Remedies Ltd. Share Price showed a sharp intraday move. After opening at Rs 243.45, the stock slipped to Rs 241.3 and then rallied to Rs 267. With the current price matching the day’s high, buyers held control through the supplied snapshot.
Key session facts are straightforward: current price Rs 267, previous close Rs 242.5, day change Rs 24.5, day change percent 10.1%, turnover Rs 0.76 crore, and market capitalisation Rs 2,246.67 crore. Based on its size, the company sits in the small-cap segment.
For readers following stocks rising today, the main takeaway is not just that the stock moved higher, but that it ended at the top of its intraday range. Even so, the dataset supports only the price move itself, not a reason behind it.
Indoco Remedies Ltd. (INDOCO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,246.67 crore |
| P/E Ratio | 397.58x |
| P/B Ratio | 2.24x |
| ROE | -10.13% |
| ROCE | 0.79% |
| EPS | Rs 0.61 |
| Book Value Per Share | Rs 108.15 |
| Dividend Yield | 0.08% |
Indoco Remedies Ltd. (INDOCO) fundamental metrics show P/E 397.58x, P/B 2.24x, ROE -10.13%, ROCE 0.79%. These figures provide context only and are not a buy or sell signal.
Indoco Remedies Ltd. has a market capitalisation of Rs 2246.67 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 397.58x, P/B at 2.24x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -10.13% and ROCE of 0.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 0.61, book value per share of Rs 108.15, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.29x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 397.58x |
| Benchmark Median P/E | 31.29x |
| Benchmark Average P/E | 48.12x |
| Benchmark P/E Range | 3.68x to 653.31x |
| Company P/B Ratio | 2.24x |
| Benchmark Median P/B | 2.88x |
| Company ROE | -10.13% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 0.79% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 2,246.67 crore |
| Benchmark Median Market Cap | Rs 720.34 crore |
Indoco Remedies Ltd. (INDOCO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Indoco Remedies Ltd. (INDOCO) has a P/E ratio of 397.58x, which is above the benchmark median of 31.29x, a difference of +1,170.63%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Indoco Remedies Ltd. (INDOCO) has a ROE of -10.13%, which is below the benchmark median of 11.79%, a difference of -185.92%. Indoco Remedies Ltd. (INDOCO) has a ROCE of 0.79%, which is below the benchmark median of 13.63%, a difference of -94.2%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,69,309.92 | 38.29 | 5.36 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,45,425.7 | 83.18 | 13.77 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,347.12 | 86.48 | 21.02 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,919.92 | 25.73 | 4.31 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,392.76 | 33.99 | 3.26 | 11.83 | 16 |
Indoco Remedies Ltd. (INDOCO) has a P/E ratio of 397.58x compared with the displayed peer median of 38.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -10.13% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 0.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Indoco Remedies Ltd. (INDOCO) has a market capitalisation of Rs 2,246.67 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Indoco Remedies Ltd.
- Indoco Remedies Ltd. Share Price rose 10.10% to Rs 267 in one session.
- The stock moved from Rs 241.3 to Rs 267 and the supplied snapshot placed it at the day’s high.
- Market capitalisation is Rs 2,246.67 crore, above the same-industry median of Rs 720.34 crore.
- P/E of 397.58 is far above the industry median of 31.29.
- ROE of -10.13 and ROCE of 0.79 remain below industry medians of 11.79 and 13.63.
About Indoco Remedies Ltd.
In the supplied dataset, Indoco Remedies Ltd. is classified under Healthcare and Pharmaceuticals & Drugs. The article’s comparisons therefore focus on same-industry metrics and large listed pharma peers such as Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. No additional operational or business-segment detail is provided in the source data, so the analysis is limited to price, valuation, profitability and market-cap context.
Track Indoco Remedies Ltd. Share Price on Univest
Use Indoco Remedies Ltd. (INDOCO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Use the Indoco Remedies Ltd. (INDOCO) live share-price page, the Univest top gainers screener, and Univest market blogs to follow live stock data, top-gainer lists and related market coverage.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Indoco Remedies Ltd. Share Price rising today?
Ans. The supplied data shows the stock rose 10.10% to Rs 267 from Rs 242.5, a gain of Rs 24.5. It confirms the move but does not establish a company-specific catalyst.
What is Indoco Remedies Ltd. Share Price today?
Ans. The supplied snapshot shows Indoco Remedies Ltd. Share Price at Rs 267. The stock opened at Rs 243.45 and traded in a range of Rs 241.3 to Rs 267. The previous close was Rs 242.5.
How does valuation compare with the industry?
Ans. The stock trades at a P/E of 397.58 versus the same-industry median of 31.29 and average of 48.12. Its P/B is 2.24 versus the industry median of 2.88 and average of 4.35.
How profitable is the company versus the industry?
Ans. ROE is -10.13 against the industry median of 11.79 and average of 11.21. ROCE is 0.79 against the industry median of 13.63 and average of 13.75. The stock belongs to the Healthcare sector.
How does Indoco compare with major pharma peers?
Ans. Compared with Sun Pharma, Divi's, Torrent Pharma, Zydus and Cipla, Indoco is much smaller by market cap, has a far higher P/E at 397.58, and lower ROE and ROCE than all 5 displayed peers.
